Episode 106: All About BFTAF

NECA in the Know

Jul 06, 2023•18 min•Ep. 106

--:--

Listen in podcast apps:

Apple Podcasts

Spotify

Download

Listen to this episode in Metacast mobile app

Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

This week, Marianna is sitting down with John Faragon to talk about the recently published five year data on treatment naïve subjects initiating therapy with bictegravir/tenofovir alafenamide/emtricitabine (that's a mouthful!) or BFTAF.

Learn all about BFTAF and why it matters for you as an HIV care provider.

--

Help us track the number of listeners our episode gets by filling out this brief form! (https://www.e2NECA.org/?r=PCS6722)

--
Want to chat? Email us at podcast@necaaetc.org with comments or ideas for new episodes.

--
Check out our free online courses: www.necaaetc.org/rise-courses

--
Download our HIV mobile apps:

Google Play Store: https://play.google.com/store/apps/developer?id=John+Faragon&hl=en_US&gl=US

Apple App Store: https://apps.apple.com/us/developer/virologyed-consultants-llc/id1216837691

For the best experience, listen in Metacast app for iOS or Android